VeonGen Therapeutics has officially announced its rebranding from ViGeneron, marking a strategic tra...

Amneal Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has approved i...

The European Commission (EC) has granted marketing authorization for Ryjunea (SYD-101), Sydnexis’ pr...

The U.S. Food and Drug Administration (FDA) has officially accepted the New Drug Application (NDA) f...

Alcon has received U.S. FDA approval for Tryptyr (acoltremon ophthalmic solution) 0.003%, formerly k...

Genentech has announced that the U.S. Food and Drug Administration (FDA) has approved Susvimo (ranib...

Grifols has announced FDA clearance of its Investigational New Drug (IND) application, allowing the ...

Belite Bio has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough T...

Atia Vision has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug...

Intalight has announced that it has received CE Mark approval for its next-generation DREAM OCT plat...